Skip to content

    Osteoporosis Health Center

    Font Size

    FDA OKs First Generic Fosamax

    Generic Versions of the Osteoporosis Drug Fosamax Shipped to Stores
    WebMD Health News
    Reviewed by Louise Chang, MD

    Feb. 6, 2008 -- The FDA today approved the first generic versions of the osteoporosis drug Fosamax (alendronate).

    Teva Pharmaceuticals will make generic Fosamax in 5-milligram, 10-milligram, and 40-milligram daily doses, and in 35-milligram and 70-milligram weekly doses. Barr Pharmaceuticals Inc. will make generic Fosamax in 70-milligram tablets, which are taken once a week. Teva and Barr have already begun shipping their generic versions of Fosamax to stores.

    "The FDA works to assure the safety and efficacy of generic drugs through a rigorous scientific and regulatory process," says Gary Buehler, RPh, director of the FDA's Office of Generic Drugs, in an FDA news release. "These approvals will provide generic options for patients who take Fosamax for their osteoporosis."

    The FDA notes that Fosamax, which is made by the drug company Merck, is among the top 100 most frequently dispensed drugs in the U.S. Fosamax had annual sales of about $1.7 billion in the U.S. for the year ending in November 2007, states a Barr news release.

    Today on WebMD

    Women working out and walking with weights
    Reduce bone loss and build stronger muscles.
    Chinese cabbage
    Calcium-rich foods to add to your diet.
    woman stretching
    Get the facts on osteoporosis.
    Porous bone
    Causes, symptoms, risk factors, and treatment.
    senior woman
    Woman holding plate of brocolli
    wrist xray
    Superfood for Bones
    mature woman
    sunlight in hands
    man and woman in front of xray
    woman with dumbbells